6.61
price down icon5.57%   -0.39
after-market 시간 외 거래: 6.70 0.09 +1.36%
loading
전일 마감가:
$7.00
열려 있는:
$5.86
하루 거래량:
134.37K
Relative Volume:
3.08
시가총액:
$611.37M
수익:
$5.12M
순이익/손실:
$-67.00M
주가수익비율:
-4.4966
EPS:
-1.47
순현금흐름:
$-38.94M
1주 성능:
-19.02%
1개월 성능:
+10.17%
6개월 성능:
-8.55%
1년 성능:
-90.88%
1일 변동 폭
Value
$5.86
$6.78
1주일 범위
Value
$5.86
$8.16
52주 변동 폭
Value
$3.816
$73.40

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
명칭
Verrica Pharmaceuticals Inc
Name
전화
484-453-3300
Name
주소
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
직원
71
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
VRCA's Discussions on Twitter

VRCA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
6.61 64.74M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-06 다운그레이드 H.C. Wainwright Buy → Neutral
2024-11-05 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-07-25 업그레이드 Needham Hold → Buy
2023-03-22 개시 Jefferies Buy
2023-02-13 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2022-05-25 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-05-14 개시 RBC Capital Mkts Outperform
2020-12-24 재확인 H.C. Wainwright Buy
2020-07-15 다운그레이드 BofA Securities Buy → Neutral
2020-06-30 재확인 H.C. Wainwright Buy
2020-06-24 개시 Northland Capital Outperform
2020-03-24 개시 Needham Buy
2019-02-21 개시 H.C. Wainwright Buy
모두보기

Verrica Pharmaceuticals Inc 주식(VRCA)의 최신 뉴스

pulisher
Jul 25, 2025

What analysts say about Verrica Pharmaceuticals Inc. stockExceptional return forecasts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Verrica Pharmaceuticals Inc. stock priceFree Stock Selection - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Verrica Pharmaceuticals Inc. stock overhyped or has real potentialFree Consultation - Newser

Jul 25, 2025
pulisher
Jul 24, 2025

VRCA Trading Halted: Anticipation Builds for Pending Announcemen - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Is Verrica Pharmaceuticals Inc. stock a good hedge against inflationRemarkably fast returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit velocity - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals Announces Reverse Stock Split - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split - Investing.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Verrica Pharmaceuticals Inc. a good long term investmentAccelerated earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 07:38:47 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying Verrica Pharmaceuticals Inc. stock nowDaily Trade Opportunity - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Verrica Pharmaceuticals Inc. stock price move sharplyInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

How Verrica Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives $8.00 Average Target Price from Brokerages - Defense World

Jul 14, 2025
pulisher
Jul 10, 2025

Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates - MyChesCo

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Down 4.9% – Should You Sell? - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 | VRCA Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales - Investing.com

Jul 09, 2025
pulisher
Jul 02, 2025

Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement - MyChesCo

Jul 02, 2025
pulisher
Jul 01, 2025

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Commo - GuruFocus

Jul 01, 2025

Verrica Pharmaceuticals Inc (VRCA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):